Seamount Financial Group’s AbbVie ABBV Stock Holding History

Seamount Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$506K	Sell	2,010 -10	-0.5%	-$2.15K	0.2%	93
2026 Q1	$439K	Sell	2,020 -91	-4%	-$20.2K	0.2%	96
2025 Q4	$482K	Sell	2,111 -25	-1%	-$5.7K	0.22%	88
2025 Q3	$495K	Hold	2,136	–	–	0.23%	83
2025 Q2	$396K	Buy	2,136 +846	+66%	+$157K	0.2%	91
2025 Q1	$270K	Sell	1,290 -210	-14%	-$40.8K	0.18%	89
2024 Q4	$267K	Hold	1,500	–	–	0.18%	92
2024 Q3	$296K	Hold	1,500	–	–	0.22%	84
2024 Q2	$257K	Sell	1,500 -29	-2%	-$4.8K	0.21%	81
2024 Q1	$278K	Hold	1,529	–	–	0.24%	77
2023 Q4	$237K	Buy	+1,529	New	+$223K	0.23%	78

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Seamount Financial Group's ABBV Position: Q2 2026 in Review

Seamount Financial Group reduced its AbbVie (ABBV) stake by 0.5% in Q2 2026, selling an estimated $2.15K and leaving 2,010 shares worth $506K. The position accounts for 0.2% of the portfolio, ranked #93.

Seamount Financial Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Seamount Financial Group held 2,010 shares of AbbVie worth $506K as of Q2 2026.
Seamount Financial Group sold 10 AbbVie shares in Q2 2026, an estimated $2.15K.
AbbVie made up 0.2% of Seamount Financial Group's portfolio in Q2 2026, its #93 holding.
Seamount Financial Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Seamount Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.